Across TCGA pan-cancer cohorts, TEX33 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TEX33 data layer compared with 13 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TEX33 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated TEX33 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, THYM, and COAD are the cancer types where TEX33 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	1.000	0.437	.013	26	view →
THYM	OS	Median	All	0.186	0.931	<.001	15	view →
COAD	OS	Median	All	0.172	0.870	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: TEX33 tumor-vs-normal RNA expression · all TEX33 data types